Cardiovascular and metabolic effects of cyclic adenosine 3', 5'-monophosphate in unanesthetized dogs.
D000227:Adenine Nucleotides / Q000494:pharmacology*; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects; D001786:Blood Glucose; D001794:Blood Pressure / Q000187:drug effects*; D002302:Cardiac Output / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D004285:Dogs; D005227:Fatty Acids; D006321:Heart / Q000187:drug effects*; D006325:Heart Atria; D006339:Heart Rate / Q000187:drug effects; D007093:Imidazoles / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008055:Lipids; D011433:Propranolol / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*; D013806:Theophylline / Q000494:pharmacology
D000227:Adenine Nucleotides; D001786:Blood Glucose; D002395:Catecholamines; D005227:Fatty Acids; D007093:Imidazoles; D008055:Lipids; D013565:Sympatholytics; D000255:Adenosine Triphosphate; D011433:Propranolol; D013806:Theophylline; D007545:Isoproterenol